Seniors Health Investigation Network - Blood Pressure Monitoring Program

ISRCTN	ISRCTN61739603
DOI	https://doi.org/10.1186/ISRCTN61739603
Secondary identifying numbers	N/A

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Plain English summary of protocol

Not provided at time of registration

Dr Janusz Kaczorowski
Scientific

1200 Main Street West HSC-2V12
Hamilton
L8N 3Z5
Canada

Study design	Randomised controlled trial
Primary study design	Interventional
Secondary study design	Single-centre
Study setting(s)	GP practice
Study type	Diagnostic
Scientific title
Study acronym	SHINE - Dundas Pilot
Study objectives	To determine the best method (mail or telephone) for family physicians offices to invite patients to attend a session, and to identify factors that predicted attendance. In preparation for a larger scale randomized controlled trial, we also performed a cost analysis of invitation method and success rate, investigated the operational and methodological aspects of the proposed intervention, and queried patients willingness to continue to attend community pharmacy blood pressure sessions and their preferences for the time and frequency of the sessions.
Ethics approval(s)	Not provided at time of registration
Health condition(s) or problem(s) studied	Hypertension
Intervention	Regular patients 65 years or older (n = 235) were randomly allocated to invitation by mail or telephone to attend pharmacy cardiovascular health awareness sessions led by volunteer peer health educators.
Intervention type	Other
Primary outcome measure	The primary end-point was the overall attendance among patients invited by mail compared to those invited by telephone.
Secondary outcome measures	Not provided at time of registration
Overall study start date	01/03/2001
Completion date	27/04/2001

Participant type(s)	Patient
Age group	Senior
Sex	Both
Target number of participants	235
Key inclusion criteria	Patients were eligible to participate if they were 65 years of age or older, considered by the physician to be regular patients, community dwelling, and able to attend a cardiovascular health promotion session in a local pharmacy.
Key exclusion criteria	Patients were excluded if they suffered from dementia or a serious, non-cardiovascular disease or condition, or were non-English speaking and could not attend with an English-speaking companion.
Date of first enrolment	01/03/2001
Date of final enrolment	27/04/2001

1200 Main Street West HSC-2V12

Hamilton
L8N 3Z5
Canada

Biovail Pharmaceuticals Canada, formerly Crystaal Corporation
Industry

7150 Mississauga Road
Mississauga, Ontario
L5N 8M5
Canada

"ROR"	https://ror.org/01zgpn844

Industry

Biovail Corporation Canada, formerly Crystaal Corporation

No information available

Intention to publish date
Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
Publication and dissemination plan	Not provided at time of registration
IPD sharing plan

Output type	Details	Date created	Date added	Peer reviewed?	Patient-facing?
Results article	Results:	19/08/2005		Yes	No